KITE PHARMA, INC.
Profile
Company Names
KITE PHARMA, INC.
Addresses
2225 COLORADO AVENUE, SANTA MONICA, CA 90404
10924 LE CONTE AVENUE, LOS ANGELES, CA 90024
Phone Numbers
(310) 824-9999
310-824-9999
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2009
State Incorporated:
DELAWARE
Total Amount Raised:
$79,123,973.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2014-04-25
$50,000,000.00
$50,000,000.00
$0.00
Debt
3
2013-05-10
$16,420,598.00
$16,420,598.00
$0.00
Equity
2
2012-11-30
$250,000.00
$250,000.00
$0.00
Equity, Debt
1
2011-02-25
$12,453,375.00
$12,522,570.00
$69,195.00
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARIE
S.
BELLDEGRUN
DIRECTOR, EXECUTIVE OFFICER
DAVID
BONDERMAN
DIRECTOR
TPG 2008 FPC, L.P.
| TPG MANAGEMENT VI-B, L.P.
| TPG MANAGEMENT VI, L.P.
| TPG 2009 VSP, L.P.
| TPG 2008 VSP, L.P.
| TPG 2009 VSC, L.P.
| TPG 2008 VSC, L.P.
| TPG 2009 FPC, L.P.
| XOJET INC
| 2009 BIOTECH VSP, L.P.
| 2009 BIOTECH VSC, L.P.
| 2010 BIOTECH VSC, L.P.
| 2010 BIOTECH VSP, L.P.
| 2010 GROWTH VSC, L.P.
| 2010 GROWTH VSP, L.P.
| TPG 2010 FPC, L.P.
| TPG 2010 VSC, L.P.
| TPG 2010 VSP, L.P.
| TPG 2011 FPC, L.P.
| ASC ACQUISITION LLC
| TPG EQUITY IV-C, L.P.
| TAC 2007 EQUITY-A, L.P.
| TPG MANAGEMENT IV-C, L.P.
| TPG STAR EQUITY-A, L.P.
| TPG STAR EQUITY-C, L.P.
| TPG BIOTECH EQUITY II-C, L.P.
| TPG BIOTECH EQUITY III-C, L.P.
| TPG BIOTECH EQUITY III-A, L.P.
| TPG VSC-A, L.P.
| TPG VSC-C, L.P.
| TPG VSC-D, L.P.
| TPG GROWTH VSC-D, L.P.
| TPG GROWTH VSC-A, L.P.
| TPG GROWTH VSC-C, L.P.
| NEWBRIDGE ASIA EQUITY IV-A, L.P.
| NEWBRIDGE ASIA EQUITY IV-C, L.P.
| NEWBRIDGE ASIA MANAGEMENT IV-A, L.P.
| NEWBRIDGE ASIA MANAGEMENT IV-C, L.P.
| TPG ASIA EQUITY V-A, L.P.
| TPG ASIA EQUITY V-C, L.P.
| TPG BIOTECH VSC-A, L.P.
| TPG BIOTECH VSC-C, L.P.
| TPG EQUITY V-A, L.P.
| TPG EQUITY V-C, L.P.
| TPG FPC, L.P.
| TPG EQUITY VI-A, L.P.
| TPG EQUITY VI-C, L.P.
| TPG VSC-B, L.P.
| TPG GROWTH VSC-B, L.P.
| TPG BIOTECH VSC-B, L.P.
| TFP CREDITCO EQUITY-C, L.P.
| TPG MANAGEMENT IV-A,L.P.
| TPG EQUITY IV-D, L.P.
| KITE PHARMA, INC.
| PROPERTY DATA HOLDINGS, L.P.
| TSL EQUITY PARTNERS, L.P.
| TPG GROWTH II FOF, L.P.
| TPG GROWTH EQUITY II-A, L.P.
| TPG GROWTH EQUITY II-B, L.P.
| TPG GROWTH EQUITY II-C, L.P.
| TSL FOF, L.P.
| TOP EQUITY II-A, L.P.
| TOP EQUITY II-B, L.P.
| TOP EQUITY II-C, L.P.
| TOP PROFESSIONALS II, L.P.
| TOP II FOF, L.P.
| FASTLANE PARENT COMPANY, INC.
| UBER TECHNOLOGIES, INC
| TPG TPEP CO-INVEST L.P.
| TPG TPEP CO-INVEST (CAYMAN), L.P.
| TPG TPEP CO-INVEST (KE), L.P.
| TICP EQUITY I, L.P.
| TPG ASIA EQUITY VI, L.P.
| TPG ASIA PROFESSIONALS VI, L.P.
| TPG ASIA VI FOF, L.P.
| TOP III FOF, L.P.
| TPG BIOTECH EQUITY IV, L.P.
| TPG PUBLIC EQUITY PARTNERS-A, L.P.
| TPG PUBLIC EQUITY PARTNERS-B, LTD.
| TOP EQUITY III-A, L.P.
| TOP PROFESSIONALS III, L.P.
| TAO EQUITY, L.P.
| TPG ART EQUITY, L.P.
| AUSTIN CREDIT MACRO EQUITY, L.P.
| TPG RE FINANCE TRUST, INC.
| TPG GROWTH EQUITY III, L.P.
| TPG GROWTH PERSONNEL III, L.P.
| TPG RE FINANCE TRUST EQUITY, L.P.
| TPG REAL ESTATE PERSONNEL II, L.P.
| TPG REAL ESTATE EQUITY II, L.P.
| TSLE EQUITY, L.P.
| TPG REAL ESTATE II FOF-QP, L.P.
| TPG GROWTH III FOF, L.P.
| TPG GROWTH III (C), L.P.
| TPG VALLEY, L.P.
| TPG EQUITY VII, L.P.
| TPG PERSONNEL VII, L.P.
| TPG PARTNERS VII (C), L.P.
| TPG FOF VII-QP, L.P.
| TPG CLO ADVISERS EQUITY II, L.P.
| TICP CLO EQUITY II, L.P.
| BCS INDIGO III, L.P.
| TSLE I VSC, L.P.
| TPG ARROW RIDGE EQUITY, L.P.
| TAO 4.0 EQUITY, L.P.
| TPG ENERGY SOLUTIONS EQUITY, L.P.
| ALLOGENE THERAPEUTICS, INC.
| TPG REAL ESTATE PARTNERS III, L.P.
| TPG REAL ESTATE PARTNERS III(A), L.P.
| TPG REAL ESTATE PARTNERS III(B), L.P.
| TPG REAL ESTATE PARTNERS III(C), L.P.
| TPG DIGITAL MEDIA PERSONNEL, L.P.
| TSSP ADJACENT OPPORTUNITIES PARTNERS (C), L.P.
| TPG TECH ADJACENCIES, L.P.
| TAO CONTINGENT EQUITY, L.P.
| TSSP ADJACENT OPPORTUNITIES PARTNERS (D), L.P.
| TSSP ADJACENT OPPORTUNITIES PARTNERS (E), L.P.
| TSSP ADJACENT OPPORTUNITIES PARTNERS (B), L.P.
| TPG HEALTHCARE PARTNERS, L.P.
| TPG PARTNERS VIII, L.P.
| TPG PUBLIC EQUITY PARTNERS LONG OPPORTUNITIES-A, L.P.
| TPG PUBLIC EQUITY PARTNERS LONG OPPORTUNITIES-B, LTD.
| TPG NEWQUEST EQUITY IV, L.P.
| RISE FUND II, L.P.
| TPG GROWTH II GATOR, L.P.
| TPG GROWTH II CAYMAN AIV GATOR, L.P.
| TPG GROWTH II DE GATOR BLOCKED FEEDER, L.P.
| TPG GROWTH II SF AIV GATOR, L.P.
| TPG GROWTH II DE AIV II, L.P.
| TPG GROWTH II DE AIV I, L.P.
| TPG STRATEGIC CAPITAL FUND, L.P.
| TPG STRATEGIC CAPITAL FUND (A), L.P.
| TPG GROWTH V, L.P.
| TPG AAF EQUITY B, L.P.
| TPG AAF EQUITY A, L.P.
| TPG RE III CINEMA CHICAGO CO-INVEST, L.P.
| TPG RISE CLIMATE, L.P.
| TPG REAL ESTATE THEMATIC ADVANTAGE CORE-PLUS REIT, LLC
| TPG RE IV NUCLEUS REIT, LLC
FARAH
CHAMPSI
DIRECTOR
ROY
DOUMANI
DIRECTOR
JOSHUA
A.
KAZAM
DIRECTOR
RAN
NUSSBAUM
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2014-04-25
